Latin America is expected to contribute in the defibrillator market, especially in the key regions including Brazil, Mexico and others. Brazil has considerable contribution in the market due to rise in heart diseases across the country. Obesity and overweight are the key factors responsible for heart diseases such as CVD, CDH, HF, and stroke. The government of Brazil is promoting AED and creating awareness about life-threatening diseases such as CVD, CHD and HF.Brazil is an emerging economy and has improved healthcare system with quality care and economic cost of surgeries. The healthcare spending of Brazil has improved over the years and the per capita income of Brazilians has risen above 25%. The defibrillator market is increasing in Brazil due to huge CVD, CHD and other heart patients.
CVD and diabetes are responsible for around 38% deaths in Brazil. However, fatality has decreased and life expectancy has improved to 73 from 52 years. Urbanization, adoption of innovative defibrillation devices, and improved healthcare system are expected to drive the Brazilian defibrillator market. Whereas, Mexico has made considerable advancement in healthcare systems in the Latin American region and enables to provide quality healthcare to the citizens at marginally higher prices. CVD, CHD, stroke, heart failure, atrial fibrillation and other heart diseases are the leading causes of fatalities in Mexico.
According to WHO, high blood pressure, hypertension, obesity, CVD, CHD, and stroke are more prevalent in Mexico; and harmful stress, depression, excessive consumption of alcohol, excessive smoking, hypertension, diabetes, obesity and poor diet are the major factors for heart diseases, which are also prevalent in Mexico. However, improvement in healthcare system and government programs to make citizen aware about heart diseases such as cardiac arrest is expected to curb fatalities. The Mexican government has implemented various healthcare schemes for its citizens. Development in healthcare system and adoption of defibrillation technology enabled to save many lives in Mexico as a result, life expectancy has increased in Mexico.
Research Methodology
The market study of the Latin American Defibrillators market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis.The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
1. Latin American Defibrillators Market Research and Analysis by Type
2. Latin American Defibrillators Market Research and Analysis by End-users
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Latin American Defibrillators Market by Type
5.1.1. Implantable Cardioverter Defibrillators
5.1.2. External Cardioverter Defibrillators
5.2. Latin American Defibrillators Market by End-Users
5.2.1. Hospitals
5.2.2. Ambulatory Services and Others
6. Regional Analysis
6.1. Brazil
6.2. Mexico
6.3. Rest of Latin America
7. Company Profiles
7.1. Abbott Laboratories Inc.
7.2. Biotronik SE & Co. KG
7.3. Fukuda Denshi Co. Ltd.
7.4. General Electric Co.
7.5. HeartSine Technologies
7.6. Koninklijke Philips N.V.
7.7. LivaNova PLC
7.8. Medtronic PLC
7.9. Nihon Kohden Corp.
1. LATIN AMERICAN DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
2. LATIN AMERICAN DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2018-2025 ($ MILLION)
3. LATIN AMERICAN DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
1. LATIN AMERICAN DEFIBRILLATORS MARKET SHARE BY TYPE, 2018 VS 2025 (%)
2. LATIN AMERICAN DEFIBRILLATORS MARKET SHARE BY END-USERS, 2018 VS 2025 (%)
3. LATIN AMERICAN DEFIBRILLATORS MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
4. BRAZIL DEFIBRILLATORS MARKET SIZE, 2018-2025 ($ MILLION)
5. MEXICO DEFIBRILLATORS MARKET SIZE, 2018-2025 ($ MILLION)
6. REST OF LATIN AMERICA DEFIBRILLATORS MARKET SIZE, 2018-2025 ($ MILLION)